New liquid embolic agent could improve brain AVM treatment
Disease control
Recruiting now
This study tests a new liquid material that blocks abnormal blood vessels in the brain. About 116 adults with brain arteriovenous malformation (AVM) will receive this treatment or a standard one. The goal is to see if the new liquid is as safe and effective at reducing the size o…
Phase: NA • Sponsor: MicroPort NeuroTech Co., Ltd. • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC